PSA levels after treatment may not be reliable predictor of survival for patients with prostate cancer

by

A UCLA-led study has found treatments that reduce the risk of being diagnosed with a cancer recurrence based on rising prostate-specific antigen (PSA) levels after radiotherapy, commonly referred to as biochemical recurrence, do not necessarily improve a patient’s long-term overall survival.

Leave A Comment

Your email address will not be published. Required fields are marked *